Fobancort

Fobancort

betamethasone + fusidic acid

Manufacturer:

Hoe Pharma

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Per cream Fusidic acid 2%, betamethasone dipropionate 0.05%. Per oint Na fusidate 2%, betamethasone dipropionate 0.05%
Indications/Uses
Inflammatory dermatoses, psoriasis, where bacterial infection caused by Staph & Strep are present or likely to occur.
Dosage/Direction for Use
Apply bd.
Contraindications
Hypersensitivity. Viral skin infections eg, vaccinia, varicella, herpes simplex, TB, acne rosacea, fungal skin infections, perioral dermatitis, ulcerative conditions.
Special Precautions
Discontinue if irritation or sensitization develop. Stasis dermatitis & other skin diseases w/ impaired circulation. Avoid contact w/ eyes. Avoid long-term continuous therapy. Pregnancy & lactation. Childn <2 yr.
Adverse Reactions
Hypersensitivity reactions eg, rashes & irritation, burning, itching, dryness, folliculitis, hypertrichosis, acneiform eruption, hypopigmentation, skin maceration, secondary infection, skin atrophy, striae & miliaria.
ATC Classification
D07CC01 - betamethasone and antibiotics ; Belongs to the class of potent (group III) corticosteroids, in combination with antibiotics. Used in the treatment of dermatological diseases.
Presentation/Packing
Form
Fobancort cream
Packing/Price
15 g x 1's;5 g x 1's
Form
Fobancort oint
Packing/Price
15 g x 1's;5 g x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in